HEATR5B

gene
On this page

Also known as KIAA1414DKFZp686P15184p200p200a

Summary

HEATR5B (HEAT repeat containing 5B, HGNC:29273) is a protein-coding gene on chromosome 2p22.2, encoding HEAT repeat-containing protein 5B (Q9P2D3). Component of clathrin-coated vesicles.

Predicted to be involved in endocytosis; protein localization; and retrograde transport, endosome to Golgi. Located in Golgi apparatus; cytosol; and nucleoplasm.

Source: NCBI Gene 54497 — RefSeq curated summary.

At a glance

  • Gene–disease (curated): pontocerebellar hypoplasia (Moderate, GenCC)
  • GWAS associations: 12
  • Clinical variants (ClinVar): 295 total — 3 likely-pathogenic
  • MANE Select transcript: NM_019024

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:29273
Approved symbolHEATR5B
NameHEAT repeat containing 5B
Location2p22.2
Locus typegene with protein product
StatusApproved
AliasesKIAA1414, DKFZp686P15184, p200, p200a
Ensembl geneENSG00000008869
Ensembl biotypeprotein_coding
OMIM619627
Entrez54497

Gene structure

Transcript identifiers

Ensembl transcripts: 18 — 15 protein_coding, 3 retained_intron

ENST00000233099, ENST00000425467, ENST00000467978, ENST00000471051, ENST00000478810, ENST00000903977, ENST00000903978, ENST00000903979, ENST00000903980, ENST00000903981, ENST00000903982, ENST00000920713, ENST00000920714, ENST00000920715, ENST00000920716, ENST00000920717, ENST00000920718, ENST00000950344

RefSeq mRNA: 1 — MANE Select: NM_019024 NM_019024

CCDS: CCDS33181

Canonical transcript exons

ENST00000233099 — 36 exons

ExonStartEnd
ENSE000003974533700563237005759
ENSE000003974563700058637000813
ENSE000007471263700230637002572
ENSE000008095983698864636988859
ENSE000008095993699064836990799
ENSE000008096013700354237003686
ENSE000008096033700705037007304
ENSE000008096043700861137008848
ENSE000014044753708426937084372
ENSE000015996893707691137077019
ENSE000016078693702065537020836
ENSE000016264633705845137058560
ENSE000016268443706058137060733
ENSE000016340833702868137028920
ENSE000016414823707548537075634
ENSE000016519693706474037064990
ENSE000016532943701384137014020
ENSE000016546883707211037072281
ENSE000016744153705731737057480
ENSE000016901503703785537038024
ENSE000016934523706868137068930
ENSE000016977203707023037070387
ENSE000017004983702792337028174
ENSE000017162223704032937040518
ENSE000017204623701980937019877
ENSE000017299093706193937062050
ENSE000017489543706575537065910
ENSE000017565633705644037056615
ENSE000017662483705888837058987
ENSE000017753123707912037079331
ENSE000017960443704113337041292
ENSE000017961473708328937083436
ENSE000017990793703262937032773
ENSE000019239183698089536981794
ENSE000034886693704965337049843
ENSE000036038643705350237053607

Expression profiles

Bgee: expression breadth ubiquitous, 261 present calls, max score 97.21.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 13.4821 / max 229.6578, expressed in 1771 samples.

FANTOM5 promoters (4 alternative TSS)

Promoter IDTPM avgSamples expressed
2775911.41481763
277581.5101620
277570.5483267
277600.00903

Top tissues by expression

261 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
left ventricle myocardiumUBERON:000656697.21gold quality
oviduct epitheliumUBERON:000480495.24gold quality
cardiac muscle of right atriumUBERON:000337994.30gold quality
ileal mucosaUBERON:000033193.30gold quality
myocardiumUBERON:000234993.04gold quality
upper arm skinUBERON:000426392.46gold quality
heart right ventricleUBERON:000208091.53gold quality
cortical plateUBERON:000534389.51gold quality
epithelial cell of pancreasCL:000008389.00silver quality
calcaneal tendonUBERON:000370188.59gold quality
cerebellar vermisUBERON:000472088.44gold quality
body of pancreasUBERON:000115088.43gold quality
tibiaUBERON:000097988.37gold quality
upper leg skinUBERON:000426288.16gold quality
skin of hipUBERON:000155488.15gold quality
thymusUBERON:000237088.06gold quality
bone marrow cellCL:000209288.03gold quality
bronchial epithelial cellCL:000232887.91gold quality
bronchusUBERON:000218587.62gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099187.04gold quality
tonsilUBERON:000237287.03gold quality
pancreasUBERON:000126486.74gold quality
Brodmann (1909) area 46UBERON:000648386.61gold quality
jejunal mucosaUBERON:000039986.24gold quality
pancreatic ductal cellCL:000207986.19silver quality
seminal vesicleUBERON:000099886.19gold quality
epithelium of nasopharynxUBERON:000195186.19gold quality
nasopharynxUBERON:000172886.17gold quality
middle temporal gyrusUBERON:000277186.16gold quality
superficial temporal arteryUBERON:000161486.01gold quality

Single-cell (SCXA)

Detected in 3 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes6.05
E-MTAB-7606no2569.38
E-MTAB-6058no284.21

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

43 targeting HEATR5B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-LET-7A-3P100.0074.033932
HSA-LET-7B-3P100.0074.083913
HSA-LET-7F-1-3P100.0074.023928
HSA-MIR-98-3P100.0074.083907
HSA-MIR-3646100.0073.565283
HSA-MIR-450A-1-3P100.0069.331837
HSA-MIR-548C-3P99.9974.017587
HSA-MIR-366299.9973.825684
HSA-MIR-428299.9975.366408
HSA-MIR-433-3P99.9869.371203
HSA-MIR-499A-5P99.9870.791323
HSA-MIR-551B-5P99.9671.283493
HSA-MIR-4666A-3P99.9671.713434
HSA-MIR-570-3P99.9672.414910
HSA-MIR-381-3P99.9371.872854
HSA-MIR-335-3P99.9373.364958
HSA-MIR-1-3P99.9372.351914
HSA-MIR-20699.9372.501893
HSA-MIR-30099.9271.762856
HSA-MIR-61399.9171.501710
HSA-MIR-369-3P99.8570.522264
HSA-MIR-607999.8468.541170
HSA-MIR-7154-5P99.6970.521900
HSA-MIR-24-3P99.5969.971934
HSA-MIR-1212399.5271.792990
HSA-MIR-671-5P99.5267.111277
HSA-MIR-448999.5065.56785
HSA-MIR-766-5P99.4767.912225
HSA-MIR-7849-3P99.4768.171224
HSA-MIR-6828-5P99.3169.211433

Literature-anchored findings (GeneRIF, showing 2)

  • Biallelic hypomorphic mutations in HEATR5B, encoding HEAT repeat-containing protein 5B, in a neurological syndrome with pontocerebellar hypoplasia. (PMID:33824466)
  • Fast-evolving cofactors regulate the role of HEATR5 complexes in intra-Golgi trafficking. (PMID:38240799)

Cross-species orthologs

5 orthologs

OrganismSymbolGene ID
danio_rerioheatr5bENSDARG00000059116
mus_musculusHeatr5bENSMUSG00000039414
rattus_norvegicusHeatr5bENSRNOG00000025926
drosophila_melanogasterCG2747FBGN0037541
caenorhabditis_elegansWBGENE00015743

Paralogs (1): HEATR5A (ENSG00000129493)

Protein

Protein identifiers

HEAT repeat-containing protein 5BQ9P2D3 (reviewed: Q9P2D3)

All UniProt accessions (2): Q9P2D3, H7C2X3

UniProt curated annotations — full annotation on UniProt →

Function. Component of clathrin-coated vesicles. Component of the aftiphilin/p200/gamma-synergin complex, which plays roles in AP1G1/AP-1-mediated protein trafficking including the trafficking of transferrin from early to recycling endosomes, and the membrane trafficking of furin and the lysosomal enzyme cathepsin D between the trans-Golgi network (TGN) and endosomes.

Subunit / interactions. Self-associates. Component of the aftiphilin/p200/gamma-synergin complex, at least composed of AFTPH/aftiphilin, HEATR5B/p200a and SYNRG/gamma-synergin, which plays a role in the AP1G1/AP-1-mediated protein trafficking from early to recycling endosomes and between the trans-Golgi network (TGN) and endosomes. Within the complex interacts with AFTPH/aftiphilin and SYNRG/gamma-synergin; the interactions are direct. Interacts with GGA1.

Subcellular location. Cytoplasm. Perinuclear region. Cytoplasmic vesicle. Clathrin-coated vesicle.

Similarity. Belongs to the HEATR5 family.

Isoforms (3)

UniProt IDNamesCanonical?
Q9P2D3-11yes
Q9P2D3-22
Q9P2D3-33

RefSeq proteins (1): NP_061897* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR011989ARM-likeHomologous_superfamily
IPR016024ARM-type_foldHomologous_superfamily
IPR040108Laa1/Sip1/HEATR5Family
IPR046837Laa1/Sip1/HEATR5-like_HEATRepeat

Pfam: PF20210, PF25468

UniProt features (14 total): modified residue 4, repeat 3, splice variant 3, sequence conflict 2, chain 1, sequence variant 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9P2D3-F181.470.35

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (4): 1123, 1563, 1564, 1737

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 81 (showing top): GCM_ZNF198, GOBP_VESICLE_MEDIATED_TRANSPORT, GOCC_COATED_VESICLE, GOBP_RETROGRADE_TRANSPORT_ENDOSOME_TO_GOLGI, CUI_TCF21_TARGETS_2_DN, GOBP_IMPORT_INTO_CELL, GOBP_ENDOCYTOSIS, GOCC_CLATHRIN_COATED_VESICLE, GOBP_CYTOSOLIC_TRANSPORT, GOCC_ENDOCYTIC_VESICLE, chr2p22, GOBP_ENDOSOMAL_TRANSPORT, GOBP_INTRACELLULAR_TRANSPORT, HES4_TARGET_GENES, HHEX_TARGET_GENES

GO Biological Process (4): endocytosis (GO:0006897), intracellular protein localization (GO:0008104), protein transport (GO:0015031), retrograde transport, endosome to Golgi (GO:0042147)

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (9): nucleoplasm (GO:0005654), Golgi apparatus (GO:0005794), cytosol (GO:0005829), membrane (GO:0016020), clathrin-coated vesicle (GO:0030136), endocytic vesicle (GO:0030139), perinuclear region of cytoplasm (GO:0048471), cytoplasm (GO:0005737), cytoplasmic vesicle (GO:0031410)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure5
cytoplasm4
vesicle budding from membrane1
membrane invagination1
vesicle-mediated transport1
import into cell1
macromolecule localization1
transport1
intracellular protein localization1
establishment of protein localization1
intercellular transport1
endosomal transport1
cytosolic transport1
binding1
nuclear lumen1
endomembrane system1
intracellular membrane-bounded organelle1
coated vesicle1
cytoplasmic vesicle1
intracellular anatomical structure1
intracellular vesicle1

Protein interactions and networks

STRING

766 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
HEATR5BSLC67A1-ASQ8N1D0473
HEATR5BGLYATL3Q5SZD4453
HEATR5BFAM174AQ8TBP5452
HEATR5BVSIG10Q8N0Z9434
HEATR5BWDR31Q8NA23417
HEATR5BSMIM3Q9BZL3412
HEATR5BTTC17Q96AE7411
HEATR5BSCFD1Q8WVM8411
HEATR5BPLEKHH3Q7Z736398
HEATR5BACP7Q6ZNF0382
HEATR5BSNTNA6NMZ2380
HEATR5BAFTPHQ6ULP2370
HEATR5BTTC23Q5W5X9369
HEATR5BSCYL2Q6P3W7367
HEATR5BWDR70Q9NW82363

IntAct

36 interactions, top by confidence:

ABTypeScore
PTPN3YWHAQpsi-mi:“MI:2364”(proximity)0.850
VAPBFAM83Gpsi-mi:“MI:0914”(association)0.730
PTPN3MCCpsi-mi:“MI:0914”(association)0.660
AP1S2AP1G1psi-mi:“MI:0914”(association)0.660
VAPAFAM83Gpsi-mi:“MI:0914”(association)0.640
ANKRD22ESYT2psi-mi:“MI:0914”(association)0.530
MLF1NDC80psi-mi:“MI:0914”(association)0.530
AURKAWDR62psi-mi:“MI:0914”(association)0.530
SCRIBHEATR5Bpsi-mi:“MI:0407”(direct interaction)0.440
DLG1HEATR5Bpsi-mi:“MI:0407”(direct interaction)0.440
AP1S2SLC43A3psi-mi:“MI:0914”(association)0.350
Xpo1IFT56psi-mi:“MI:0914”(association)0.350
APBB1SSPOPpsi-mi:“MI:0914”(association)0.350
ESR1ESYT2psi-mi:“MI:0914”(association)0.350
CLTACLTBpsi-mi:“MI:0914”(association)0.350
GPR17TMEM120Bpsi-mi:“MI:0914”(association)0.350
EFNA4NBASpsi-mi:“MI:0914”(association)0.350
RAB43TRAPPC13psi-mi:“MI:0914”(association)0.350
NPTNRTL8Cpsi-mi:“MI:0914”(association)0.350
AP1B1SYNJ1psi-mi:“MI:0914”(association)0.350
AP1S3AP1G1psi-mi:“MI:0914”(association)0.350
AP1M2AP1G1psi-mi:“MI:0914”(association)0.350

BioGRID (80): HEATR5B (Affinity Capture-MS), HEATR5B (Affinity Capture-MS), HEATR5B (Affinity Capture-MS), HEATR5B (Affinity Capture-MS), HEATR5B (Affinity Capture-MS), HEATR5B (Affinity Capture-MS), HEATR5B (Affinity Capture-MS), HEATR5B (Affinity Capture-MS), HEATR5B (Affinity Capture-MS), HEATR5B (Affinity Capture-MS), HEATR5B (Affinity Capture-MS), HEATR5B (Affinity Capture-MS), HEATR5B (Affinity Capture-MS), HEATR5B (Affinity Capture-MS), HEATR5B (Proximity Label-MS)

ESM2 similar proteins: A0JP94, A1A5F2, A1EC95, A2BID5, A9JRI0, E7FAW3, E7FBU4, E9PVA8, F4HRS2, F4IP13, K8ERU3, O35095, O43299, P42695, P49815, P49816, Q08CY4, Q0DJS1, Q28205, Q2KJ97, Q3U829, Q3UHQ6, Q5JWR5, Q5PRF0, Q5R5R2, Q5SPP5, Q5ZIG0, Q61037, Q640K1, Q642P2, Q68F70, Q6AI08, Q6GN08, Q6GPP1, Q6P1G0, Q6ZNJ1, Q6ZQA0, Q6ZQK0, Q7T006, Q7ZY56

Diamond homologs: A0JP94, A1A5F2, Q5PRF0, Q86XA9, Q8C547, Q8JFV4, Q9P2D3, P39526

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 38 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters5113.3×2e-08
The role of Nef in HIV-1 replication and disease pathogenesis5113.3×2e-08
Lysosome Vesicle Biogenesis781.6×3e-10
Host Interactions of HIV factors560.0×5e-07
trans-Golgi Network Vesicle Budding545.3×2e-06
Golgi Associated Vesicle Biogenesis642.9×1e-07
HIV Infection521.2×5e-05
MHC class II antigen presentation619.1×1e-05

GO biological processes:

GO termPartnersFoldFDR
synaptic vesicle endocytosis565.5×3e-06
intracellular protein transport815.7×4e-06
vesicle-mediated transport514.6×7e-04

Disease & clinical

Clinical variants and AI predictions

ClinVar

295 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic3
Uncertain significance244
Likely benign8
Benign0

Top pathogenic / likely-pathogenic (3)

Variant IDHGVSClassification
2429105NM_019024.3(HEATR5B):c.1615C>T (p.Arg539Ter)Likely pathogenic
992892NM_019024.3(HEATR5B):c.5051-1G>ALikely pathogenic
992893NM_019024.3(HEATR5B):c.5050+4A>GLikely pathogenic

SpliceAI

6366 predictions. Top by Δscore:

VariantEffectΔscore
2:36981792:CTC:Cacceptor_gain1.0000
2:36981793:TC:Tacceptor_gain1.0000
2:36981794:CC:Cacceptor_gain1.0000
2:36981795:C:CCacceptor_gain1.0000
2:36988638:ATACT:Adonor_loss1.0000
2:36988639:TACTT:Tdonor_loss1.0000
2:36988640:ACTT:Adonor_loss1.0000
2:36988641:CT:Cdonor_loss1.0000
2:36988642:TTACT:Tdonor_loss1.0000
2:36988643:TA:Tdonor_loss1.0000
2:36988644:A:ACdonor_gain1.0000
2:36988644:ACT:Adonor_loss1.0000
2:36988645:C:CAdonor_gain1.0000
2:36988645:C:Gdonor_loss1.0000
2:36988645:CT:Cdonor_gain1.0000
2:36988645:CTG:Cdonor_gain1.0000
2:36988645:CTGT:Cdonor_gain1.0000
2:36988645:CTGTT:Cdonor_gain1.0000
2:37000580:GGTTA:Gdonor_loss1.0000
2:37000581:GTTA:Gdonor_loss1.0000
2:37000582:TTACC:Tdonor_loss1.0000
2:37000583:TACCT:Tdonor_loss1.0000
2:37000584:A:ATdonor_loss1.0000
2:37000585:C:Adonor_loss1.0000
2:37000810:CATC:Cacceptor_gain1.0000
2:37002347:A:Cdonor_gain1.0000
2:37002374:T:Adonor_gain1.0000
2:37003540:A:ACdonor_gain1.0000
2:37003541:C:CGdonor_gain1.0000
2:37003545:G:Cdonor_gain1.0000

AlphaMissense

13395 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
2:37008665:C:GD1490H1.000
2:37008683:A:GW1484R1.000
2:37008683:A:TW1484R1.000
2:37013846:C:GA1427P1.000
2:37013849:A:GW1426R1.000
2:37013849:A:TW1426R1.000
2:37013950:A:GL1392P1.000
2:37013953:A:GL1391P1.000
2:37013971:A:GL1385P1.000
2:37014006:C:AW1373C1.000
2:37014006:C:GW1373C1.000
2:37014008:A:GW1373R1.000
2:37014008:A:TW1373R1.000
2:37019851:A:CF1354L1.000
2:37019851:A:TF1354L1.000
2:37019853:A:GF1354L1.000
2:37019864:A:GL1350P1.000
2:37019867:G:TA1349D1.000
2:37020674:A:GL1339P1.000
2:37020691:A:CF1333L1.000
2:37020691:A:TF1333L1.000
2:37020693:A:GF1333L1.000
2:37020737:A:GL1318P1.000
2:37020746:A:GL1315P1.000
2:37020749:C:TG1314E1.000
2:37020750:C:AG1314W1.000
2:37020750:C:GG1314R1.000
2:37020750:C:TG1314R1.000
2:37020790:G:CF1300L1.000
2:37020790:G:TF1300L1.000

dbSNP variants (sampled 300 via entrez): RS1000041110 (2:37009492 G>A), RS1000046415 (2:36984584 A>G), RS1000061893 (2:37037330 A>G), RS1000151344 (2:37083994 A>C,G), RS1000175946 (2:36999728 C>T), RS1000217757 (2:37004545 T>C), RS1000231200 (2:37078772 C>T), RS1000241044 (2:37005520 A>G), RS1000244742 (2:37040908 A>G), RS1000262246 (2:37078465 T>A), RS1000309890 (2:36993602 T>C), RS1000313954 (2:37051106 C>T), RS1000330881 (2:36994728 A>C), RS1000346874 (2:37034848 G>A), RS1000372322 (2:37072449 A>G)

Disease associations

OMIM: gene MIM:619627 | disease phenotypes: MIM:618501

GenCC curated gene-disease

DiseaseClassificationInheritance
pontocerebellar hypoplasiaModerateAutosomal recessive

Mondo (2): cerebellar atrophy with seizures and variable developmental delay (MONDO:0032788), pontocerebellar hypoplasia (MONDO:0020135)

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

12 associations (top):

StudyTraitp-value
GCST007103_4QRS duration1.000000e-08
GCST007104_4QRS duration1.000000e-13
GCST007267_282Systolic blood pressure6.000000e-09
GCST008163_2Height4.000000e-06
GCST008972_261Urate levels4.000000e-08
GCST010697_37Cortical surface area (min-P)6.000000e-31
GCST010698_20Subcortical volume (min-P)1.000000e-08
GCST010699_106Brain morphology (min-P)2.000000e-11
GCST010700_34Cortical thickness (MOSTest)2.000000e-08
GCST010701_57Cortical surface area (MOSTest)4.000000e-16
GCST010702_109Subcortical volume (MOSTest)1.000000e-09
GCST010703_96Brain morphology (MOSTest)6.000000e-46

EFO canonical traits (4, from GWAS)

EFO IDTrait name
EFO:0006335systolic blood pressure
EFO:0004531urate measurement
EFO:0004346neuroimaging measurement
EFO:0004840cortical thickness

MeSH disease descriptors (1)

DescriptorNameTree numbers
C580383Pontocerebellar Hypoplasia (supp.)

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

29 total (human), top 29 by PubMed support.

ChemicalActions (top 5)PubMed papers
Valproic Acidaffects cotreatment, decreases expression2
FR900359decreases phosphorylation1
triphenyl phosphateaffects expression1
bisphenol Adecreases expression1
tetrabromobisphenol Adecreases expression1
manganese chloridedecreases expression, increases abundance1
benzo(e)pyreneincreases methylation1
potassium chromate(VI)affects cotreatment, decreases expression1
nickel sulfatedecreases expression1
beta-methylcholineaffects expression1
epigallocatechin gallateaffects cotreatment, decreases expression1
di-n-butylphosphoric acidaffects expression1
K 7174increases expression1
ICG 001decreases expression1
2,2’,4,4’-tetrabromodiphenyl etherdecreases expression1
pentabrominated diphenyl ether 100decreases expression1
4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic aciddecreases expression1
Arsenic Trioxidedecreases expression1
Benzo(a)pyreneaffects methylation1
Dinitrochlorobenzenedecreases expression1
Doxorubicindecreases expression1
Eugenoldecreases expression1
Hydralazineaffects cotreatment, decreases expression1
Ivermectindecreases expression1
Manganeseincreases abundance, decreases expression1
Methapyrileneincreases methylation1
Urethaneincreases expression1
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxidedecreases expression1
Aflatoxin B1decreases methylation, increases methylation1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.